TRxADE Health Inc reports results for the quarter ended in June - Earnings Summary

Scienture Holdings

25/07/2022 23:41

* TRxADE Health Inc  MEDS.OQ  reported a quarterly adjusted
loss
of 13 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 72.7% to $3.28 million from a year ago;
analysts
expected $2.93 million. 
    * TRxADE Health Inc's reported EPS for the quarter was a
loss
of 13 cents​.
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TRxADE Health Inc shares had risen by 3.1% this
quarter and
lost 29.2% so far this year.
    * The company reported a quarterly loss of $1.08 million.
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data July 25
at 10:41 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.08          -0.13          Missed
 Mar. 31 2022      -0.11          -0.12          Missed
 Dec. 31 2021      -0.15          -0.10          Beat
 Sep. 30 2021      -0.13          -0.16          Missed